Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view.
A NatalicchioN MarranoM MontagnaniM GalloA FaggianoM C ZatelliA ArgentieroM Del ReS D'OronzoS FogliT FranchinaD GiuffridaS GoriA RagniG MarinoR MazzilliM MonamiL MorviducciV RenzelliA RussoL SciaccaE TuveriA CortelliniM Di MaioR CandidoF PerroneG AimarettiA AvogaroN SilvestrisFrancesco GiorginoPublished in: Journal of endocrinological investigation (2024)
The current review seeks to summarize the available evidence on the effect of glycemic control on cancer outcomes, as well as on the possibility that timely treatment of hyperglycemia and improved glycemic control in patients with cancer and diabetes may favorably affect cancer outcomes.